LEI: 213800HBLQNH5FXXGE63
10 January 2024
Volex plc
("Volex" or the "Company")
Issue of Equity and Total Voting Rights
Volex announces that, pursuant to its scrip dividend alternative for the interim dividend of 1.4 pence per share for the half year ended 1 October 2023 to be paid on 10 January 2024, elections were received in respect of 46,924,909 ordinary shares of 25 pence each in the Company ("Ordinary Shares") as at the scrip election date of 15 December 2023. Accordingly, 213,776 Ordinary Shares (the "Scrip Dividend Shares") will be issued in satisfaction of such elections at the scrip reference price of 307.3 pence each.
Application has been made to the London Stock Exchange for the Scrip Dividend Shares to be admitted to AIM. It is expected that dealings in the Scrip Dividend Shares will commence at 8.00 a.m. on 12 January 2024.
The Scrip Dividend Shares will rank pari passu in all respects with the existing Ordinary Shares of the Company.
Total voting rights
Following admission of the Scrip Dividend Shares, the Company's total issued share capital will consist of 181,617,533 ordinary shares of 25 pence each with one voting right per share.
As the Company does not hold any shares in treasury, the total number of voting rights in the Company is also 181,617,533 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
For further information please contact:
Volex plc +44 (0)7971 156 431
Nat Rothschild, Executive Chairman
Jon Boaden, Chief Financial Officer
Chris Bedford, Group General Counsel and Company Secretary
Peel Hunt LLP ‐ Nominated Adviser & Joint Broker +44 (0)20 7418 8900
Ed Allsopp
Tom Ballard
Ben Harrington
HSBC Bank plc ‐ Joint Broker +44 (0)20 7991 8888
Simon Alexander
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
